Wealthcare Advisory Partners LLC Sarepta Therapeutics, Inc. Transaction History

Wealthcare Advisory Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 29, 2020	SELL	$93.0 - $171.7 $10,509 - $19,402	-113 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$82.38 - $131.64 $4,283 - $6,845	-52 Reduced 31.52%	113 $11,000
Q1 2019 May 13, 2019	SELL	$106.67 - $151.68 $3,733 - $5,308	-35 Reduced 17.5%	165 $20,000
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $144,137 - $201,887	-1,250 Reduced 86.21%	200 $32,000
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $89,675 - $192,112	1,250 Added 625.0%	1,450 $192,000
Q3 2017 Nov 15, 2017	BUY	$35.73 - $47.15 $7,145 - $9,430	200	200 $9,000

560

85.5M

3.67M

1.75M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.